APA (7th ed.) Citation

P, J., R, K., S, Z., CY, O., L, N., L, N., . . . ML, W. (2021). Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. American journal of hematology, 96(5), E137. https://doi.org/10.1002/ajh.26109

Chicago Style (17th ed.) Citation

P, Jain, et al. "Outcomes of Relapsed Mantle Cell Lymphoma Patients After Discontinuing Acalabrutinib." American Journal of Hematology 96, no. 5 (2021): E137. https://doi.org/10.1002/ajh.26109.

MLA (9th ed.) Citation

P, Jain, et al. "Outcomes of Relapsed Mantle Cell Lymphoma Patients After Discontinuing Acalabrutinib." American Journal of Hematology, vol. 96, no. 5, 2021, p. E137, https://doi.org/10.1002/ajh.26109.